The Use of Patient Reported Outcomes (Pros) By the Pharmaceutical Industry in Japan – A Brief Review of Pmda Data in Comparison With Fda and Ema-Approved Label Claims
Nov 1, 2014, 00:00
10.1016/j.jval.2014.08.1605
https://www.valueinhealthjournal.com/article/S1098-3015(14)03535-9/fulltext
Title :
The Use of Patient Reported Outcomes (Pros) By the Pharmaceutical Industry in Japan – A Brief Review of Pmda Data in Comparison With Fda and Ema-Approved Label Claims
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)03535-9&doi=10.1016/j.jval.2014.08.1605
First page :
A517
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1080